THE structurally related natural products rapamycin and FK506 bind to the same intracellular
receptor, FKBP12, yet the resulting complexes interfere with distinct signalling pathways 1,…

Recent evidence indicates that sensory and motor changes may precede the cognitive
symptoms of Alzheimer's disease (AD) by several years and may signify increased risk of …

The main neurological manifestation of COVID-19 is loss of smell or taste. The high incidence
of smell loss without significant rhinorrhea or nasal congestion suggests that SARS-CoV-2 …

Background The mechanisms by which any upper respiratory virus, including SARS-CoV-2,
impairs chemosensory function are not known. COVID-19 is frequently associated with …

University of Pennsylvania Smell Identification Test data from control subjects (n = 63), patients
with mild cognitive impairment (n = 147), and patients with Alzheimer's disease (n = 100) …

Clinical trials of novel therapeutics for Alzheimer’s Disease (AD) have consumed a large
amount of time and resources with largely negative results. Repurposing drugs already …

We describe two convenient and flexible methods for controlling the attachment and spreading
of mammalian cells on solid surfaces using patterned, self-assembled monolayers (SAMs…

The cDNA encoding human cyclophilin from the Jurkat T-cell lymphoma line has been cloned
by the expression cassette polymerase chain reaction and sequenced, and an expression …

Metformin, a diabetes drug with anti-aging cellular responses, has complex actions that may
alter dementia onset. Mixed results are emerging from prior observational studies. To …

Background The literature regarding clinical olfaction, olfactory loss, and olfactory dysfunction
has expanded rapidly over the past two decades, with an exponential rise in the past year. …